United States, Bristol-Myers Squibb headquarters.
Bristol-Myers Squibb's performance during this period was very good.
In addition to traditional drug and equipment sales, the most critical thing is the severe lung disease treatment center established in Maple Leaf Country in cooperation with Changtian Technology, which is running very well.
It has successfully treated thousands of patients, and its total revenue will soon exceed 1 billion US dollars.
This is a real money printing machine.
Although the 2007 financial report has not yet been released, Bristol-Myers Squibb can be sure that the group's revenue and profits will hit a record high last year.
The ability to achieve such results is inseparable from the cooperation between Changtian Technology.
Although Cassian, the vice president of Bristol-Myers Squibb, had some unpleasant things with Changtian Technology during the first negotiation, the final result was good, so Cassian received great attention from the group company.
In 2008, Mr. Burgat, the group's CEO, will retire.
Both the senior management of the group company and the board of directors hope that Cassian can be elected as the head of Bristol-Myers Squibb.
Becoming the head of Bristol-Myers Squibb means being able to control more resources, and it also means having better wealth.
Not to mention other things, even in the critical treatment center that cooperates with Changtian Technology, those brokers who have relationships with senior executives within the company group can earn quite a lot of commissions by introducing a big customer to get treatment by jumping in line.
If Cassian can successfully be elected as the CEO of Bristol-Myers Squibb, the profits behind it are self-evident.
Western pharmaceutical companies.
Everything is business.
As Cassian plotted his future campaign.
Bristol-Myers Squibb suddenly received an urgent letter from Changtian Technology.
The letter requires the Department of Social Security to do everything possible to supply osimertinib to Changtian Technology within a week.
If Bristol-Myers Squibb cannot complete the corresponding work in accordance with Changtian Technology's requirements, Changtian Technology will immediately terminate its comprehensive cooperation with Bristol-Myers Squibb.
Seeing such a letter from Changtian Technology, Cassian's back felt a little chilly.
As an executive of a pharmaceutical company, Xia Guo has made various efforts during this period, hoping to make it known to everyone that he can obtain osimertinib.
Cassian also knew that the people using osimertinib were not ordinary people, but Xia Guo's aviation engine experts.
Although osimertinib is still in the experimental process, judging from the current animal experiments and clinical trials, the effect is quite good.
Therefore, many pharmaceutical giants and industry experts in the United States predict that after its launch, osimertinib will become the most popular targeted drug for middle- and late-stage cancer in the world.
Now Changtian Technology is putting pressure on Bristol-Myers Squibb so directly, which Cassian did not expect.
When Bristol-Myers Squibb cooperated with Changtian Technology, because Changtian Technology was in a strong position, the two parties did not sign any compensation issues regarding the sudden termination of the contract by Changtian Technology.
That is to say, during the cooperation process between the two parties, Changtian Technology was in a strong position from the beginning to the end.
Changtian Technology can terminate the contract and terminate the cooperation at any time without receiving any compensation.
Now Changtian Technology is putting pressure on Bristol-Myers Squibb at all costs, and it is obvious that it is willing to go all out.
Changtian Technology’s approach definitely violates the relevant standards of the United States.
But who cares?
The one with the hard fist is the boss.
Revenue from intensive care centers has become Bristol-Myers Squibb's biggest profit point.
If Bristol-Myers Squibb loses such a big profit point, it will be more than worth the loss.
Many things are like this. You can take tonics, but you can't take laxatives. If you eat them in your mouth, it's easy to spit them out, but it's difficult to spit them out.
This letter requires a very tight schedule and the corresponding medicines should be provided within a week.
Cassian did not dare to make the decision without authorization and immediately reported the relevant situation to the company's senior management.
Bristol-Myers Squibb's senior management held an emergency meeting. After discussion, all senior management agreed that the Maple Leaf National Critical Care Center, which was finally established, could never be canceled arbitrarily.
Bristol-Myers Squibb will use all possible means to obtain relevant drugs from AstraZeneca.
Chen Xiao's guess was not wrong at all.
Several giant pharmaceutical companies in the United States restrict each other and also cooperate with each other.
Bristol-Myers Squibb definitely has a trump card that AstraZeneca is afraid of.
Also receiving letters were companies such as Johnson & Johnson and Pfizer.
The situation of the two companies is the same as that of Bristol-Myers Squibb. They both cooperate with Changtian Technology, and their profits are very generous.
If we lose our cooperation with Changtian Technology because of this trivial matter, it will really be a loss that outweighs the gain.
Among them, Pfizer's annual profits from critical care treatment in Mexico are already higher than some of Pfizer's brand-name drugs.
Businessmen pursue profit, and losing this profit is more painful than having flesh cut off from their bodies.
Pfizer and other companies have acted urgently to start negotiations with AstraZeneca.
Ask AstraZeneca to provide osimertinib immediately.
Pfizer and AstraZeneca also have many scientific and technological collaborations.
In terms of cancer-targeted drugs, both parties actually share patents.
So AstraZeneca currently faces a dilemma.
On the one hand, there is pressure from relevant departments in the United States, requiring AstraZeneca to prohibit providing any targeted drugs to Xia Guo.
On the other hand, this is pressure from American capital.
The capital behind pharmaceutical companies represented by Pfizer, Johnson & Johnson and Bristol-Myers Squibb is demanding that AstraZeneca immediately provide relevant drugs as soon as possible to calm the anger from Xia Guochangtian Technology.
American politics serves capital.
All political decisions are aimed at allowing capital to grow better.
So AstraZeneca has little choice but to compromise with capital.
He immediately provided osimertinib drugs to three companies.
AstraZeneca still had its own considerations in doing so.
Even if the relevant departments of the United States are offended and fined, such losses are much more cost-effective than offending the three giant companies of Bristol-Myers Squibb, Johnson & Johnson, and Pfizer, and the capital behind them.
AstraZeneca's volume is wherever it is, and it still has many patents on drugs and equipment.
It is absolutely impossible for the relevant departments in the United States to let AstraZeneca disappear because of this incident.
At this moment, in the critical treatment center on Tianyue Island in Xia Kingdom.
Qu Ping's team is working hard to complete the combined colony and lung resection surgery on He Jiang.
He Jiang's lungs are quite fragile.
Being bedridden for a long time greatly increased his chances of lung infection.
If the lungs are not removed at this time, even if the combined colony surgery is successful, lung infection will cause He Jiang to become critically ill.
Therefore, Qu Ping's team teamed up with relevant medical staff from Fudan University Cancer Center and took the risk to perform emergency surgery on He Jiang.
The leaders and colleagues of this 606 institute felt unhappy.
They came here originally hoping that He Jiang could explain some technical work.
Unexpectedly, the day he met He Jiang, He Jiang was lying on the bed unable to say a word.
Colleagues at Institute 606 could sense that He Jiang was eager to communicate with everyone, but his physical condition did not allow it.
So now they can only hope that the operation will be successful.
If the operation fails, even if my turbofan 10 engine can be finally perfected, it will all be gone in the Year of the Monkey.
The institute is already racing against time.
Relevant departments of Xia State. We also learned that the country was undergoing surgery.
Moreover, the news from He Jiang’s treatment team at Fudan University Affiliated Hospital is that He Jiang’s chance of success in surgery is very low, and leaders of relevant departments are asked to prepare for the worst.
After Liang Fei got the news, he felt very heavy and extremely angry inside.
He felt that some things should not be hidden.
Why does He Jiang's situation happen?
The most critical reason is that many domestic drug research institutions are overstaffed and are thinking of ways to make money and defraud scientific research funds. No one can calm down and engage in scientific research.
The project on targeted cancer drugs actually started 20 years ago.
However, in the past 20 years, wherever scientific research projects have been established, there have been very few people actually engaged in relevant scientific research.
"The Point Guard Is Here"
Why?
This somewhat deformed scientific research environment is inseparable.
For a scientific research that lasts for more than 10 years, if you do not produce any achievements in the end, these 10 years will be wasted and the funds will be wasted.
Among those experts and researchers who can stand in scientific research institute experiments, which one is not the top of the pyramid?
I finally got to this position after studying hard for decades, and of course I wanted to make as much money as possible.
Therefore, many projects that yield quick results are done intensively and intensively.
As for those projects that need to be settled down and carried out step by step, no one cares about them at all.
This is why Xia Guo's Internet applications have been able to develop greatly in a short period of time, while targeted anti-cancer drugs and chip technology are the fundamental reasons why they have stalled.
Because by developing Internet applications, you can get huge profits in a very short period of time.
As for making chips or making targeted drugs for cancer, it is very likely that you will have toiled and worked in obscurity for decades without any results, and there will be no reward for your efforts.
Liang Fei reported this matter to Yanjing's senior officials and hoped that Xiaguo TV Station could truthfully announce He Jiang's deeds and related circumstances.
The purpose of this is to inspire scientific researchers in Xia State, especially those young people who are about to enter the scientific research industry.
We must clearly understand the severe situation that Xia Guo is currently facing in the high-end pharmaceutical industry. We encourage everyone not to care about temporary gains and losses and to do research with peace of mind.
Most of the elites in Xia Kingdom made a lot of money from projects that were both fast and low-income.
Once a project is completed, you may earn tens or even millions of dollars very quickly.
But if you really put your mind down, do research well, and make breakthroughs in cancer-targeted drugs and other similar projects that require long-term scientific research and investment, then the mobile phone you get may be hundreds of millions or even tens of billions of dollars.
The rose of time is especially fragrant in scientific research projects, but many people are not willing to wait.
After receiving the instructions from the relevant departments, He Jiang remained unknown for decades and made a turbofan 10 engine, and the United States tried every means to block the country from obtaining targeted drugs such as osimertinib. Related news is being reported overwhelmingly in Xia Kingdom.
In addition to Xia Guo TV, heavyweight paper media such as "Huanhuan Times", "Shenxiao" and "Yanjing Daily", as well as online media such as Xinlang and Souhu, are reporting frantically.
Countless ordinary people in Xia Kingdom felt very angry when they saw such news, and they felt worried and anxious about He Jiang's condition.
"The white-skinned pig is so bad! In order to kill one of our engineers, he tried every possible means to ban the sale of drugs!"
"I also see a lot of anger, but I can't say that. All the current measures taken by American companies are in line with relevant American requirements. After all, targeted drugs for late-stage cancer like osimertilib are originally in the experimental process. There is no external sales, and even if they are, they have no cooperation agreement with us, so it is normal for the other party not to provide drugs."
"I feel so sad! Chinese people have to rely on foreign medicine for their own lives!"
"Extremely angry! Why can't we produce a drug with the same efficacy?"
"I fully understand the feeling upstairs, but producing anti-cancer drugs is not a simple matter. It involves many industries, especially the life science industry. There is a huge gap between our country and the United States in basic science. The foundation is decades behind, let alone such high-tech achievements.”
"What about Changtian Technology? Isn't Changtian Technology awesome? Why can't there be a way to save Professor He Jiang?"
"Please use your brain when you speak upstairs. How many years has Changtian Technology been established? It is already quite remarkable to have achieved what it has today! You can't ask a private company to compete alone with the entire elite team in the United States! "
"I agree with the statement above! When you are ridiculing Changtian Technology, you should think about the fact that there are many pharmaceutical companies and research institutes in Xia State. They receive so much national funding every year, but they don't dare to fart!"
At this time, in Changzezhou, Suzhou and Hangzhou.
The coping strategies given by Chen Xiao are indeed very effective.
Both Bristol-Myers Squibb, Pfizer, Johnson & Johnson and other companies have provided Osimertinib, currently in the trial phase, to Changtian Technology as soon as possible.
Moreover, these companies have assured Changtian Technology that all drugs come from AstraZeneca, that the drugs are adequately controlled, and that there are no legal or economic risks.
When Qu Ping was the first to get the news, she excitedly ran to Chen Xiao's office to report to Chen Xiao.
Qu Ping knew He Jiang's condition and it was very likely that even after taking osimertinib, he would not be able to be completely cured and could only prolong his life as much as possible.
But having this medicine is better than not having it.
Chen Xiao didn't look very happy when he got such news.
He had expected such a result.
After all, with the huge profits, the three pharmaceutical companies that were notified will definitely try their best.
However, Chen Xiao felt that this kind of head-to-head confrontation with fists should be done less frequently.
Changtian Technology still needs to be more powerful, so powerful that as long as you raise your fist, it will make others feel afraid, instead of asking the other party to test whether your fist is strong.
The United States, an intelligence agency.
Bellito, who was in charge of the He Jiang project, smashed the table in anger when he learned that Changtian Technology had obtained the drug!
Bellito believed that what Changtian Technicians did was to fly above his own head!
